Drug Delivery Systems And Interfaces
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. For the treatment of human diseases, nasal and pulmonary routes of
drug delivery are gaining increasing importance. These routes provide promising alternatives to parenteral
drug delivery particularly for
peptide and protein therapeutics. For this purpose, several
drug delivery systems have been formulated and are being investigated for nasal and pulmonary delivery. These include liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins, among others. Nasal and respiratory organ routes of
drug delivery are gaining importance for the treatment of human diseases. These routes give promising alternatives to
drug delivery significantly for amide and super molecule medicine. For this purpose, many
drug delivery systems are developed and are researching on nasal and respiratory organ delivery. These embrace liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins among others.
Nanoparticles composed of perishable
polymers show assurance in fulfilling the tight needs placed on these delivery systems, like ability to be transferred into aerosol, stability against forces generated throughout aerosolization, biocompatibility.
High Impact List of Articles
-
The role of hypodermic injection with low dose of adrenaline in emergency treatment of severe asthma
Weiguo Gong, Jiange Jiang, Houzhen Fan
Research Article: Pharmaceutical Bioprocessing
-
The role of hypodermic injection with low dose of adrenaline in emergency treatment of severe asthma
Weiguo Gong, Jiange Jiang, Houzhen Fan
Research Article: Pharmaceutical Bioprocessing
-
The Tat pathway as a biotechnological tool for the expression and export of heterologous proteins in Escherichia coli
Kelly L Walker, Alexander S Jones and Colin Robinson*
Review Article: Pharmaceutical Bioprocessing
-
The Tat pathway as a biotechnological tool for the expression and export of heterologous proteins in Escherichia coli
Kelly L Walker, Alexander S Jones and Colin Robinson*
Review Article: Pharmaceutical Bioprocessing
-
In situ microscopy and MIR-spectroscopy as non-invasive optical sensors for cell cultivation process monitoring
Christian Luder, Patrick Lindner, David Bulnes-Abundis, Shaobin M Lu, Tim Lucking, Dorte Solle* and Thomas Scheper
Research Article: Pharmaceutical Bioprocessing
-
In situ microscopy and MIR-spectroscopy as non-invasive optical sensors for cell cultivation process monitoring
Christian Luder, Patrick Lindner, David Bulnes-Abundis, Shaobin M Lu, Tim Lucking, Dorte Solle* and Thomas Scheper
Research Article: Pharmaceutical Bioprocessing
-
A microfluidic approach to high throughput quantification of host cell protein impurities for bioprocess development
Jun Hyuk Heo*, Xiaodun Mou, Fengqiang Wang, John M Troisi, Christopher W Sandifer, Suzanne Kirby, Dennis Driscoll, Suzanne Mercorelli and David J Pollard
Research Article: Pharmaceutical Bioprocessing
-
A microfluidic approach to high throughput quantification of host cell protein impurities for bioprocess development
Jun Hyuk Heo*, Xiaodun Mou, Fengqiang Wang, John M Troisi, Christopher W Sandifer, Suzanne Kirby, Dennis Driscoll, Suzanne Mercorelli and David J Pollard
Research Article: Pharmaceutical Bioprocessing
-
Recombinant protein and mAb biopharmaceuticals to become a commodity?
Emile van Corven*
Editorial: Pharmaceutical Bioprocessing
-
Recombinant protein and mAb biopharmaceuticals to become a commodity?
Emile van Corven*
Editorial: Pharmaceutical Bioprocessing
Relevant Topics in Clinical